Pharmaceuticals Market Research Reports & Industry Analysis

Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.

The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.

The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.

Publications found: 28,272
Sort by:

Pulmonary Embolism (Cardiovascular) - Drugs In Development, 2021

US$ 2,000.00

Pulmonary Embolism (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pulmonary Embolism (Cardiovascular) - Drugs...

June 2021 44 pages

Restenosis (Cardiovascular) - Drugs In Development, 2021

US$ 2,000.00

Restenosis (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Restenosis (Cardiovascular) - Drugs In Development,...

June 2021 40 pages

Sandhoff Disease (Jatzkewitz-Pilz Syndrome) (Genitourinary Disorders) - Drugs In Development, 2021

US$ 2,000.00

Sandhoff Disease (Jatzkewitz-Pilz Syndrome) (Genitourinary Disorders) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Sandhoff...

June 2021 53 pages

Somatostatin Receptor Type 4 (SSTR4) - Drugs In Development, 2021

US$ 3,500.00

Somatostatin Receptor Type 4 (SSTR4) - Drugs In Development, 2021 SUMMARY Somatostatin Receptor Type 4 (SSTR4) pipeline Target constitutes close to 5 molecules. The latest report Somatostatin Receptor...

June 2021 41 pages

Spinal Muscular Atrophy (SMA) (Central Nervous System) - Drugs In Development, 2021

US$ 2,000.00

Spinal Muscular Atrophy (SMA) (Central Nervous System) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Spinal Muscular Atrophy...

June 2021 186 pages

Trigeminal Neuralgia (Tic Douloureux) (Central Nervous System) - Drugs In Development, 2021

US$ 2,000.00

Trigeminal Neuralgia (Tic Douloureux) (Central Nervous System) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Trigeminal Neura...

June 2021 80 pages

Tyrosine Protein Kinase Mer - Drugs In Development, 2021

US$ 3,500.00

Tyrosine Protein Kinase Mer - Drugs In Development, 2021 SUMMARY According to the recently published report 'Tyrosine Protein Kinase Mer - Drugs In Development, 2021'; Tyrosine Protein Kinase Mer (Pro...

June 2021 94 pages

Vaccine Delivery Devices: Global Markets

US$ 5,500.00

Report This report provides a detailed description of vaccine delivery devices and the latest technologies in the market. The report includes market estimates for different types of vaccine delivery...

June 2021 141 pages

What’s Ahead for the Animal Health Industry?-Emerging Opportunities and Growth Strategies for Suppliers

US$ 2,750.00

Will the industry consolidate, decentralize, or undergo a bimodal transformation?How will the current trends affect the major market segments?Which companies will enter the market and which will not s...

June 2021 110 pages

Investigation Report on China's Recombinant human thrombopoietin (rhTPO) Market 2021-2025

US$ 2,600.00

... with thrombopenia increases in China, the demand for Recombinant Human Thrombopoietin will also increase. Considering the high growth rate of the Recombinant Human Thrombopoietin market, Recombinant Human Thrombopoietin products by other ...

June 2021 50 pages

Investigation Report on China's Acetylcysteine Market 2021-2025

US$ 2,600.00

Acetylcysteine, also known as N-acetylcysteine (NAC), is a medication that is used to treat paracetamol (acetaminophen) overdose, and to loosen thick mucus in individuals with chronic bronchopulmonary...

June 2021 50 pages

Investigation Report on China's Anlotinib Market 2021-2025

US$ 2,600.00

Anlotinib is an oral multi-targeting small-molecule tyrosine kinase inhibitor that can target multiple angiogenic factor receptors to inhibit tumor angiogenesis. It can be used for advanced non-small...

June 2021 50 pages

Investigation Report on China's Dexmedetomidine Market 2021-2025

US$ 2,600.00

Dexmedetomidine is a highly selective ?2-adrenergic receptor agonist. It is mainly used clinically for the sedation of tracheal intubation and mechanical ventilation in surgical patients undergoing ge...

June 2021 50 pages

Investigation Report on China's Doxorubicin Market 2021-2025

US$ 2,600.00

Doxorubicin belongs to the anthracycline class (Anthracycline) antibiotics, which can inhibit the synthesis of RNA and DNA. It has a strong inhibitory effect on RNA and has a broad anti-tumor spectrum...

June 2021 50 pages

Investigation Report on China's Emtricitabine/Tenofovir Market 2021-2025

US$ 2,600.00

Emtricitabine/Tenofovir is the first HIV drug approved for prophylaxis. It was developed by Gilead Sciences Inc (the original drug is called TRUVADA). Its product was first approved in the United Stat...

June 2021 50 pages

Investigation Report on China's Enteral Nutrition Market 2021-2025

US$ 2,600.00

Enteral nutrition is mainly used for preoperative feeding of patients with anorexia and related diseases, including mechanical gastrointestinal dysfunction, critical illness and malnutrition. It was d...

June 2021 50 pages

Investigation Report on China's Express Delivery Industry 2021-2025

US$ 2,600.00

Express delivery is a door-to-door logistics activity with postal functions, which means express companies use rail, road, and air transportation to quickly deliver customers' goods. According to CRI’...

June 2021 50 pages

Investigation Report on China's Goserelin Market 2021-2025

US$ 2,600.00

Goserelin is a synthetic analogue of a naturally occurring gonadotropin-releasing hormone (GnRH). Goserelin is developed by AstraZeneca, is mainly used to treat advanced breast and prostate cancer. In...

June 2021 50 pages

Investigation Report on China's Hydrotalcite Market, 2021-2025

US$ 2,600.00

Hydrotalcite is suitable for acute and chronic gastritis, reflux esophagitis, gastric and duodenal ulcers, stomach pain, heartburn, acid belching, fullness and other uncomfortable symptoms related to...

June 2021 50 pages

Investigation Report on China's Insulin Glargine Market 2021-2025

US$ 2,600.00

Insulin Glargine is a long-acting human insulin analog that can control the patient's blood sugar more effectively and steadily. It is often used to treat type 1 and type 2 diabetes. Its original rese...

June 2021 50 pages

Investigation Report on China's Leuprorelin Market 2021-2025

US$ 2,600.00

Leuprolide is a synthetic gonadotropin drug used to treat hormone-responsive cancers such as prostate cancer and breast cancer. It can also be used to treat precocious puberty and prevent premature ov...

June 2021 50 pages

Investigation Report on China's Levofloxacin Market 2021-2025

US$ 2,600.00

Levofloxacin, developed by Daiichi Sankyo, is used to treat bacterial infectious diseases such as community pneumonia, sinusitis, urinary tract infections. Levofloxacin tablets were approved in China...

June 2021 50 pages

Investigation Report on China's Moxifloxacin Market 2021-2025

US$ 2,600.00

Moxifloxacin is a fourth-generation synthetic quinolone antibacterial drug (8-methoxy-fluoroquinolone antibiotic) developed by Bayer Vital GmbH. It was approved for marketing by the FDA in December 19...

June 2021 50 pages

Investigation Report on Global and China's MOSFET Market 2021-2025

US$ 2,600.00

MOSFET is an acronym for Metal Oxide Semiconductor Field Effect Transistor, also known as MOS, MOS transistor. The name 'metal–oxide–semiconductor' (MOS) typically refers to a type of insulated-gate f...

June 2021 50 pages

Global Erythropoietin Drugs Market Size study, By Drug Class (Biologics, Biosimilars), By Product (Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa, Others), By Application (Cancer, Hematology, Neurology and Renal Diseases) and Regional Forecasts 2021-2027

US$ 3,000.00

Global Erythropoietin Drugs Market is valued approximately USD 11.05 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 11.30% over the forecast period 2021-2027. Eryth...

June 2021 200 pages

Global Pharmaceutical Contract Manufacturing Market Size study, by Services (Pharmaceutical Manufacturing Services, Drug Development Services and Biologics Manufacturing Services), End-Use (Big, Medium and Small Pharmaceutical Companies, Generic Pharmaceutical Companies And Others) and Regional Forecasts 2021-2027

US$ 3,000.00

Global Pharmaceutical Contract Manufacturing Market is valued approximately USD 99.8 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 7.5% over the forecast period 20...

June 2021 200 pages

Global Vitamin D Therapy Market Size study, by Route of administration (Oral and Parenteral), Age Group (Children, Adult, Senior Adult), Purchase Pattern (OTC, Prescription), Application (Osteoporosis, Rickets, Autoimmune Disorder, Skin Diseases and Others) and Regional Forecasts 2021-2027

US$ 3,000.00

Global Vitamin D Therapy Market is valued approximately USD 2.11 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 11.3% over the forecast period 2021-2027. Vitamin D...

June 2021 200 pages

Pharmaceutical Caps and Closures Market Size study, by Product Type (Screw-on Caps, Dispensing Caps and Others) by Technology (Injection Moulding, Compression Moulding, Post-mould TE Band, Others) By Raw Material (PP, HDPE, LDPE and others), By End-use (Beverage, Pharmaceuticals and others) and Regional Forecasts 2021-2027.

US$ 3,000.00

Global Pharmaceutical Caps and Closures Market is valued at approximately USD 34.50 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 5.4% over the forecast period 202...

June 2021 200 pages

Investigation Report on China's Daratumumab Market 2021-2025

US$ 2,600.00

Daratumumab, developed by Johnson & Johnson, is a monoclonal antibody available for the treatment of myeloma. Its product DARZALEX was approved for the treatment of patients with multiple myeloma who...

June 2021 50 pages

Investigation Report on China's Docetaxel Market 2021-2025

US$ 2,600.00

Docetaxel, sold under the brand name Taxotere, is a paclitaxel anti-tumor drug used for the treatment of locally advanced or metastatic non-small cell lung cancer. Docetaxel injection was first develo...

June 2021 50 pages

Investigation Report on China's Liraglutide Market 2021-2025

US$ 2,600.00

Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, developed by Novo Nordisk A/S. Its product VICTOZA firstly launched in the EU in July 2009 and firstly approved to enter the Chinese...

June 2021 50 pages

Investigation Report on China's Omalizumab Market 2021-2025

US$ 2,600.00

Omalizumab, developed by Novartis Europharm, is the only approved antibody designed to target and block immunoglobulin E (IgE). At the end of 2017, the FDA approved the registration of Novartis Europh...

June 2021 50 pages

Investigation Report on China's Oxaliplatin Market 2021-2025

US$ 2,600.00

Oxaliplatin (OXA) is the third-generation platinum anti-tumor drug after cisplatin and carboplatin. Oxaliplatin was jointly developed by Sanofi and Debiopharm for the first-line treatment of metastati...

June 2021 50 pages

Investigation Report on China's Pantoprazole Market 2021-2025

US$ 2,600.00

Pantoprazole is the third proton pump inhibitor marketed globally. Compared with omeprazole, it has higher selectivity and bioavailability. Pantoprazole is more stable than omeprazole and lansola unde...

June 2021 50 pages

Investigation Report on China's Pertuzumab Market 2021-2025

US$ 2,600.00

Pertuzumab is the first monoclonal antibody called 'HER dimerization inhibitor'. It mainly used to treat HER2-positive breast cancer. It was developed by Genentech, a subsidiary of Roche Pharma (Schwe...

June 2021 50 pages

Investigation Report on China's Rabeprazole Market 2021-2025

US$ 2,600.00

Rabeprazole is a kind of proton pump inhibitor (PPI) gastric acid inhibitor. It is used for the treatment of gastroesophageal reflux disease and maintenance treatment after recovery. It is also suitab...

June 2021 50 pages

Investigation Report on China's Ruxolitinib Market 2021-2025

US$ 2,600.00

Ruxolitinib was developed by Novartis Pharma Schweiz AG. It is an orally bioavailable Janus-associated kinase (JAK) inhibitor with selectivity for subtypes JAK1 and JAK2. Its product is used for the t...

June 2021 50 pages

Investigation Report on China's Sitagliptin Market 2021-2025

US$ 2,600.00

Sitagliptin is the world's first listed oral dipeptidyl peptidase-4 (DPP-4) inhibitor, developed by Merck Sharp & Dohme Ltd (JANUVIA). It was approved by the U.S. FDA in October 2006 to be used as a s...

June 2021 50 pages

Drug Discovery Informatics - Global Market Outlook (2020-2028)

US$ 4,150.00

... Drug Discovery Informatics market. However, Lack of information technology and critical attributes of data evaluation are limiting the market growth. The recent trends in Drug Discovery Informatics are considerable shift observed from traditional in-vitro drug development to computer aided drug designing, as costly failures of late drug development increases ...

June 2021 150 pages

Acne vulgaris - Pipeline Insight, 2021

US$ 2,000.00

... clients within 5 Days 'Acne Vulgaris - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Acne Vulgaris development. The report provides ...

June 2021 70 pages

Angina pectoris - Pipeline Insight, 2021

US$ 1,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Angina (Angina Pectoris) The report also ...

June 2021 60 pages

Cachexia - Pipeline Insight, 2021

US$ 2,000.00

... clients within 48 Hours 'Cachexia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Cachexia development. The report provides detailed ...

June 2021 80 pages

Diabetic foot ulcer - Pipeline Insight, 2021

US$ 2,000.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Diabetic Foot Ulcers The report also ...

June 2021 80 pages

Pruritus - Pipeline Insight, 2021

US$ 2,000.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Pruritus - Pipeline Insight, 2019 The report also ...

June 2021 90 pages

Vulvovaginal candidiasis - Pipeline Insight, 2021

US$ 1,500.00

... clients within 48 Hours 'Vulvovaginal Candidiasis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Vulvovaginal Candidiasis development. The report provides ...

June 2021 60 pages

Post-traumatic stress disorders - Pipeline Insight, 2021

US$ 1,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Post-Traumatic Stress Disorder (PTSD) The report also ...

June 2021 60 pages

Urea cycle disorders - Pipeline Insight, 2021

US$ 1,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Urea Cycle Disorders The report also ...

June 2021 60 pages

Adenoid cystic carcinoma - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 24 Hours DelveInsight’s, “Adenoid cystic carcinoma - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipe...

June 2021 60 pages

Allergic rhinitis - Pipeline Insight, 2021

US$ 2,000.00

This report can be delivered to the clients within 72 Hours DelveInsight’s, “Allergic rhinitis - Pipeline Insight, 2021,” report provides comprehensive insights about 35+ companies and 35+ pipeline...

June 2021 90 pages

Diffuse large B cell lymphoma - Pipeline Insight, 2021

US$ 2,500.00

This report can be delivered to the clients within 72 Hours DelveInsight’s, “Diffuse large B cell lymphoma - Pipeline Insight, 2021,” report provides comprehensive insights about 80+ companies and 8...

June 2021 60 pages

Filters

Search

Categories

153
14,653
11,965
339
73
1,089

Publishers

72
1
1,760
342
531
292
33
4
1,887
635
92
3,251
8
109
111
554
55
5
5
6
23
18
27
205
30
34
6,128
13
12
142
363
8
25
84
385
8
14
49
179
7
2,002
139
579
2,786
7
24
44
31
54
61
7
2,538
40
34
11
22
16
38
2
4
83
4
26
50
1
141
11
118
36
20
61
32
50
33
27
32
42
326
877
49
88
82
59
37
2
14
22
2

Regions

8
7
7
7
7
7
7
6
6
5
3
2
2
1
1
1
247
59
50
48
47
46
42
27
22
22
19
18
17
16
15
15
15
14
14
14
14
14
14
13
13
13
13
13
13
13
13
13
13
13
13
12
12
12
12
11
11
11
11
11
10
10
10
10
10
9
9
9
7
6
6
5
184
13
12
8
431
236
126
56
49
33
29
8
7
6
6
6
6
6
5
5
5
4
3
3
5
5
5
4
3
1
1
1
1
1
2
2
77
25,666

Price

—

Date

—

Pages

—

Offers

44
5
1